亚太药业
(002370)
| 流通市值：19.43亿 | | | 总市值：19.43亿 |
| 流通股本：6.09亿 | | | 总股本：6.09亿 |
| 报告期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 720,474,524.86 | 705,494,767.43 | 710,867,246.18 | 739,004,798.75 |
| 应收票据及应收账款 | 79,510,294.14 | 102,782,322.69 | 100,559,502.77 | 93,931,211.57 |
| 应收账款 | 79,510,294.14 | 102,782,322.69 | 100,559,502.77 | 93,931,211.57 |
| 应收款项融资 | 32,288,532.83 | 9,280,796.7 | 11,932,110.37 | 19,049,000 |
| 预付款项 | 4,244,178.55 | 5,057,877.57 | 2,087,845.54 | 2,667,740.79 |
| 其他应收款合计 | 15,522,715.91 | 16,773,054.61 | 16,909,045.14 | 14,752,255.52 |
| 存货 | 89,474,526.05 | 74,377,775.46 | 80,930,318.41 | 93,315,823.99 |
| 其他流动资产 | 13,665,221.37 | 14,442,108.52 | 15,000,255.14 | 15,592,588.43 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 955,179,993.71 | 928,208,702.98 | 938,286,323.55 | 978,313,419.05 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 37,750,771.34 | 39,767,793.58 | 37,556,930.67 | 44,353,061.5 |
| 投资性房地产 | 645,941.76 | 11,802,441.8 | 11,979,251.39 | 12,156,060.98 |
| 固定资产 | 364,754,927.4 | 363,256,689.8 | 369,667,892.54 | 376,752,798.41 |
| 在建工程 | 33,628.32 | 33,628.32 | 417,768.32 | 741,628.32 |
| 使用权资产 | - | - | - | 1,192,163.15 |
| 无形资产 | 59,206,059.34 | 59,356,307.35 | 60,779,507.43 | 58,084,469.55 |
| 开发支出 | 11,133,234.46 | 13,633,484.41 | 13,633,484.41 | 17,608,797.85 |
| 长期待摊费用 | 232,518.69 | 272,416.89 | 312,315.09 | 2,025,245.93 |
| 其他非流动资产 | 436,332.8 | - | - | - |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 474,193,414.11 | 488,122,762.15 | 494,347,149.85 | 512,914,225.69 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,429,373,407.82 | 1,416,331,465.13 | 1,432,633,473.4 | 1,491,227,644.74 |
| 流动负债: | | | | |
| 短期借款 | 50,059,583.33 | 50,054,166.67 | 50,054,166.67 | 50,085,479.45 |
| 应付票据及应付账款 | 51,796,562.84 | 45,245,770.69 | 47,145,617.8 | 89,650,144.34 |
| 其中：应付票据 | 2,320,000 | 10,074,500 | 7,754,500 | 30,370,000 |
| 应付账款 | 49,476,562.84 | 35,171,270.69 | 39,391,117.8 | 59,280,144.34 |
| 预收款项 | 68,807.35 | 113,669.78 | 347,889.93 | 688,899.12 |
| 合同负债 | 7,893,839.01 | 2,587,305.59 | 2,719,844.39 | 2,111,535.5 |
| 应付职工薪酬 | 11,728,418.48 | 7,070,988.72 | 7,422,599.88 | 7,400,948.99 |
| 应交税费 | 5,460,868.95 | 2,307,573.3 | 4,771,728.31 | 3,903,860.48 |
| 其他应付款合计 | 33,768,550.24 | 36,195,117.85 | 40,352,325.48 | 38,458,089.69 |
| 一年内到期的非流动负债 | 0 | - | - | 1,709,825.55 |
| 其他流动负债 | 1,026,199.07 | 336,349.73 | 353,579.77 | 274,499.61 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 161,802,829.27 | 143,910,942.33 | 153,167,752.23 | 194,283,282.73 |
| 非流动负债: | | | | |
| 应付债券 | 639,476,620.42 | 811,494,229.25 | 910,889,766.67 | 898,147,206.02 |
| 租赁负债 | 0 | - | - | - |
| 预计负债 | 38,043,600 | 38,043,600 | 38,043,600 | 89,832,376.9 |
| 递延收益 | 5,564,676.14 | 5,879,850.16 | 6,195,024.18 | 6,510,198.2 |
| 递延所得税负债 | 3,611,272.46 | 3,877,700.53 | 3,349,907.93 | 3,853,094.87 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 686,696,169.02 | 859,295,379.94 | 958,478,298.78 | 998,342,875.99 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 848,498,998.29 | 1,003,206,322.27 | 1,111,646,051.01 | 1,192,626,158.72 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 609,171,060 | 564,439,830 | 536,687,059 | 536,686,959 |
| 其他权益工具 | 139,396,735.7 | 179,369,501.87 | 204,170,115.93 | 204,170,243.29 |
| 资本公积 | 1,593,849,797.33 | 1,417,767,963.75 | 1,310,076,263.12 | 1,310,075,675.49 |
| 其他综合收益 | -598,381.19 | -598,381.19 | -598,381.19 | -598,381.19 |
| 盈余公积 | 60,559,514.31 | 60,559,514.31 | 60,559,514.31 | 60,559,514.31 |
| 未分配利润 | -1,821,504,316.62 | -1,808,413,285.88 | -1,789,907,148.78 | -1,812,292,524.88 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 580,874,409.53 | 413,125,142.86 | 320,987,422.39 | 298,601,486.02 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 580,874,409.53 | 413,125,142.86 | 320,987,422.39 | 298,601,486.02 |
| 负债和股东权益合计 | 1,429,373,407.82 | 1,416,331,465.13 | 1,432,633,473.4 | 1,491,227,644.74 |
| 公告日期 | 2024-03-30 | 2023-10-28 | 2023-08-26 | 2023-04-29 |
| 审计意见(境内) | 标准无保留意见 | | | |